Axogen Inc (AXGN)
12.48
-0.06
(-0.48%)
USD |
NASDAQ |
Nov 14, 16:00
12.48
0.00 (0.00%)
After-Hours: 20:00
Axogen Research and Development Expense (Quarterly): 6.996M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.996M |
| June 30, 2024 | 6.658M |
| March 31, 2024 | 7.409M |
| December 31, 2023 | 8.169M |
| September 30, 2023 | 6.694M |
| June 30, 2023 | 7.144M |
| March 31, 2023 | 6.326M |
| December 31, 2022 | 6.811M |
| September 30, 2022 | 7.05M |
| June 30, 2022 | 7.022M |
| March 31, 2022 | 6.275M |
| December 31, 2021 | 6.302M |
| September 30, 2021 | 6.404M |
| June 30, 2021 | 5.723M |
| March 31, 2021 | 5.748M |
| December 31, 2020 | 4.931M |
| September 30, 2020 | 4.23M |
| June 30, 2020 | 4.071M |
| March 31, 2020 | 4.614M |
| December 31, 2019 | 4.912M |
| September 30, 2019 | 4.181M |
| June 30, 2019 | 4.282M |
| March 31, 2019 | 4.139M |
| December 31, 2018 | 3.806M |
| September 30, 2018 | 3.307M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.601M |
| March 31, 2018 | 2.058M |
| December 31, 2017 | 1.971M |
| September 30, 2017 | 1.795M |
| June 30, 2017 | 1.521M |
| March 31, 2017 | 1.411M |
| December 31, 2016 | 1.178M |
| September 30, 2016 | 1.118M |
| June 30, 2016 | 0.9368M |
| March 31, 2016 | 0.9783M |
| December 31, 2015 | 0.8937M |
| September 30, 2015 | 0.936M |
| June 30, 2015 | 0.7364M |
| March 31, 2015 | 0.671M |
| December 31, 2014 | 0.9837M |
| September 30, 2014 | 0.6812M |
| June 30, 2014 | 0.5558M |
| March 31, 2014 | 0.8126M |
| December 31, 2013 | 0.6266M |
| September 30, 2013 | 0.5936M |
| June 30, 2013 | 0.4983M |
| March 31, 2013 | 0.4069M |
| December 31, 2012 | 0.3733M |
| September 30, 2012 | 0.3904M |
| June 30, 2012 | 0.3674M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.071M
Minimum
Jun 2020
8.169M
Maximum
Dec 2023
6.174M
Average
6.365M
Median
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 4.353M |
| IRIDEX Corp | 1.501M |
| Stereotaxis Inc | 2.273M |
| Electromed Inc | 0.176M |
| Myomo Inc | 1.249M |